Overview
Oxana Lungu practices practicing medicine in Parma, Italy.
Her clinical expertise encompasses Smoldering Multiple Myeloma, Multiple Myeloma, and Osteolysis Syndrome Recessive.
She is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Oxana Lungu
Is Oxana Lungu a top-rated expert for Smoldering Multiple Myeloma?
MediFind is an objective health platform that identifies experts based on real-world data. Oxana Lungu is classified as an Experienced expert for Smoldering Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Oxana Lungu participate in research or clinical trials?
Yes. Oxana Lungu has published 9 articles and abstracts on conditions like Smoldering Multiple Myeloma. You can view a list of Oxana Lungu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Multiple MyelomaMs. Lungu isExperienced. Learn about Multiple Myeloma.
- Osteolysis Syndrome RecessiveMs. Lungu isExperienced. Learn about Osteolysis Syndrome Recessive.
- Smoldering Multiple MyelomaMs. Lungu isExperienced. Learn about Smoldering Multiple Myeloma.